CSL Combines with Aventis to Create ZLB Behring
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)
Published: 4 Feb-2004
DOI: 10.3833/pdr.v2004.i44.832 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
CSL acquired Aventis Behring, the blood products business of Aventis, in a deal that has rendered CSL the industry’s second largest manufacturer of plasma products...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS